ClinicalTrials.Veeva

Menu

Spinal Plasticity to Enhance Motor Retraining After Stroke

VA Office of Research and Development logo

VA Office of Research and Development

Status

Completed

Conditions

Cerebrovascular Accident
Stroke
Hemiparesis

Treatments

Other: Sham stimulation
Other: Paired corticospinal-motoneuronal stimulation (PCMS)

Study type

Interventional

Funder types

Other U.S. Federal agency

Identifiers

NCT03645122
1617296 (Other Grant/Funding Number)
B2837-W

Details and patient eligibility

About

The objective of this project is to study the effects of an emerging noninvasive neuromodulation strategy in human stroke survivors with movement-related disability. Muscle weakness after stroke results from the abnormal interaction between cells in the brain that send commands to control movement and cells in the spinal cord that cause muscles to produce movement. The neuromodulation strategy central to this project has been shown the strengthen the physical connection between both cells, producing a change in movement potential of muscles weakened by stroke.

Full description

Stroke is a leading cause of serious long-term disability in the United States with 795,000 individuals suffering a new or recurrent stroke each year. In most cases, disability is associated with incomplete motor recovery of the paretic limb. Full recovery is often not achieved, creating a need for neuromodulation strategies that target the physiological mechanisms impaired by stroke to fully harness the adaptive capacity of the nervous system. The neuromodulation protocol that will be tested in these experiments will target connections between the brain and spinal cord with noninvasive stimulation to enhance movement potential of the hand. Individuals who experienced a single stroke at least 6 months ago may be eligible to participate.

Enrollment

23 patients

Sex

All

Ages

18 to 75 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Between the ages of 18 and 75 years old
  • Diagnosis of first-ever stroke
  • Stroke onset of at least six months prior to the time of participation

Exclusion criteria

  • History of seizure or epilepsy
  • Ferromagnetic metallic implants, pacemakers, other implanted devices, or ventilators (for subjects undergoing MRI)
  • Pregnant or expecting to become pregnant
  • Difficulty maintaining alertness and/or remaining still
  • Body weight > 300 lbs due to MRI scanner dimensions (for subjects undergoing MRI)
  • Cognitive or language impairments that would interfere with the ability to follow simple instructions, as judged by the investigators
  • Diagnosis of movement disorder(s) other than stroke

Trial design

Primary purpose

Basic Science

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

None (Open label)

23 participants in 3 patient groups

PCMS REST
Experimental group
Description:
PCMS will be triggered while the hand/digits are at rest.
Treatment:
Other: Paired corticospinal-motoneuronal stimulation (PCMS)
SHAM
Active Comparator group
Description:
SHAM stimulation will be triggered when a criterion level of force stability by the hand/digits is achieved.
Treatment:
Other: Sham stimulation
PCMS ACTIVE
Experimental group
Description:
PCMS will be triggered when a criterion level of force stability by the hand/digits is achieved.
Treatment:
Other: Paired corticospinal-motoneuronal stimulation (PCMS)

Trial documents
2

Trial contacts and locations

1

Loading...

Central trial contact

Michael A Urbin, PhD; Nicholas J Gatto, BS

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems